These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 31465739

  • 1. A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2.
    Liu M, Degner J, Georgantas RW, Nader A, Mostafa NM, Teixeira HD, Williams DA, Kirsner RS, Nichols AJ, Davis JW, Waring JF.
    J Invest Dermatol; 2020 Mar; 140(3):574-582.e2. PubMed ID: 31465739
    [Abstract] [Full Text] [Related]

  • 2. Adalimumab: A Review in Hidradenitis Suppurativa.
    Kim ES, Garnock-Jones KP, Keam SJ.
    Am J Clin Dermatol; 2016 Oct; 17(5):545-552. PubMed ID: 27665300
    [Abstract] [Full Text] [Related]

  • 3. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
    Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB.
    N Engl J Med; 2016 Aug 04; 375(5):422-34. PubMed ID: 27518661
    [Abstract] [Full Text] [Related]

  • 4. Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa.
    Argyropoulou M, Trigoni A, Kaffenberger J, Stergianou D, Damoraki G, Mingiani E, Micha S, Krispinsky A, Meltzanidou P, Kanni T, Lazaridou E, Giamarellos-Bourboulis EJ.
    Dermatology; 2023 Aug 04; 239(5):746-752. PubMed ID: 37331331
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC.
    Expert Rev Clin Immunol; 2016 Oct 04; 12(10):1015-26. PubMed ID: 27531618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
    Caposiena Caro RD, Cannizzaro MV, Tartaglia C, Bianchi L.
    Clin Exp Dermatol; 2020 Jun 04; 45(4):438-444. PubMed ID: 31630436
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adalimumab (Humira) for the Treatment of Hidradenitis Suppurativa.
    Gupta AK, Studholme C.
    Skin Therapy Lett; 2016 Jul 04; 21(4):1-4. PubMed ID: 27388530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of patients with hidradenitis suppurativa.
    Martorell A, Caballero A, González Lama Y, Jiménez-Gallo D, Lázaro Serrano M, Miranda J, Pascual JC, Salgado-Boquete L, Marín-Jiménez I.
    Actas Dermosifiliogr; 2016 Sep 04; 107 Suppl 2():32-42. PubMed ID: 28081768
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hidradenitis suppurativa in association with keratitis-ichthyosis-deafness syndrome treated with adalimumab.
    Song YM, Kim YS, Lee JH, Park YM, Lee JY.
    J Dermatol; 2018 Sep 04; 45(9):e262-e263. PubMed ID: 29570225
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study.
    Kanni T, Argyropoulou M, Spyridopoulos T, Pistiki A, Stecher M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ.
    J Invest Dermatol; 2018 Apr 04; 138(4):795-801. PubMed ID: 29129600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.